The Global Biopsy Devices Market to Exhibit Growth at a CAGR of ~5% by 2027 | DelveInsight

New York, USA, March 27, 2023 (GLOBE NEWSWIRE) — The Global Biopsy Devices Market to Exhibit Growth at a CAGR of ~5% by 2027 | DelveInsight

The biopsy devices market is experiencing positive growth as a result of various factors such as rising breast cancer prevalence, increasing geriatric population, rising incidence of lung cancer, and increasing technological advancements in product offerings. As a result, the biopsy devices market is expected to expand between 2022 and 2027.

DelveInsight’s Biopsy Devices Market Insights report provides the current and forecast market analysis, individual leading biopsy devices companies’ market shares, challenges, biopsy devices market drivers, barriers, and trends, and key biopsy devices companies in the market.

Key Takeaways from the Biopsy Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global biopsy devices market during the forecast period. 
• Notable biopsy devices companies such as Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc, B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM, INRAD Inc, Hologic Inc, C. R. Bard, Dr. Japan Co Ltd, Limaca-medical, Owlstone Medical Ltd, Zamar Care, KOELIS, ST. STONE MEDICAL DEVICES PVT LTD, Iscon Surgicals Ltd, and several others are currently operating in the biopsy devices market.
• In February 2023, TransMed7, LLC announced that Dr. Michael Berry, a distinguished surgeon and member of the American Society of Breast Surgeons (ASBrS), successfully performed the “First in Human” series of clinical cases using commercial production Concorde US devices (a member of the new Concorde family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Soft Tissue Biopsy devices) have been successfully performed by Dr. Michael Berry, distinguished surgeon and member of the American Society of Breast Surgeons (ASBrS), performing breast biopsy cases at the Margaret West Comprehensive Breast Center in Germantown, TN.
• In September 2022, Merit Medical Systems announced the release of the Temno Elite soft tissue biopsy system in the United States.
• In May 2022, Limaca Medical, a privately held company located in Israel devoted to enhancing endoscopic biopsy outcomes for patients with potentially life-threatening gastrointestinal tumors, gained FDA breakthrough device classification for its Precision GI endoscopic ultrasound biopsy device. Precision GI is deployed and operated through an instrument channel in the endoscope to biopsy a tumor.
• In May 2022, Limaca Medical, a privately held company located in Israel devoted to enhancing endoscopic biopsy outcomes for patients with potentially life-threatening gastrointestinal tumors, and HekaBio K.K., is a privately held healthcare company based in Tokyo, Japan, announced that they had inked a strategic partnership agreement, whereby HekaBio is to distribute Limaca’s Precision-GI™ Endoscopic Biopsy Device in Japan.

To read more about the latest highlights related to the biopsy devices market, get a snapshot of the key highlights entailed in the Global Biopsy Devices Market Report

Biopsy Devices Overview

Biopsy is a surgical procedure that removes tissue from an organ to determine the presence or extent of a disease, most commonly cancerous and inflammatory conditions. Surgeons, radiologists, and interventional cardiologists are the most common people who perform it. Biopsies can be performed on any organ using specific biopsy devices as a confirmatory test for cancer and celiac disease. The application of each biopsy device differs depending on the type of organ under consideration. Conventional biopsy devices can be supplemented with advanced imaging technologies such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others to perform a biopsy with accuracy and minimal invasiveness. Biopsies on body organs such as the lungs, liver, and kidneys are performed using these integrated procedures.

Biopsy Devices Market Insights

North America dominated the global biopsy devices market in 2021, and it is expected to do so again during the forecast period of 2022–2027. Factors such as rising lung cancer incidence are expected to drive up demand for biopsy devices in the North American market. Furthermore, rising technological advancements in product offerings drive the biopsy devices market growth. For instance, in May 2022, Limaca Medical, a privately held company located in Israel devoted to enhancing endoscopic biopsy outcomes for patients with potentially life-threatening gastrointestinal tumors, gained FDA breakthrough device classification for its Precision GI endoscopic ultrasound biopsy device. Precision GI is deployed and operated through an instrument channel in the endoscope to biopsy a tumor.

To know more about why North America is leading the market growth in the biopsy devices market, get a snapshot of the Biopsy Devices Market Outlook 

Biopsy Devices Market Dynamics

The rising prevalence of breast cancer is one of the primary drivers of the biopsy devices market. Furthermore, the growing geriatric population is an important factor driving the growth of biopsy devices. However, complications associated with biopsy procedures, such as bleeding, infections, and others, and alternative biopsy therapies, such as blood tests, may impede the growth of the global biopsy devices market.

Additionally, the ongoing COVID-19 outbreak has significantly impacted the biopsy devices market. The nationwide lockdown in almost every country restricted people’s movement, halted supply chains and logistics, hampered manufacturing rates, resulting in a product shortage in the market, and elective surgeries were not prioritized because COVID-19 patients were given priority treatment.

However, with the mass vaccination of the population, the relaxation of lockdown restrictions, the resumption of supply chains, logistics, and manufacturing units, and an increase in elective surgeries, the biopsy devices market has gained traction and is expected to grow further during the forecast period.

Get a sneak peek at the biopsy devices market dynamics @ Biopsy Devices Market Dynamics Analysis

Biopsy Devices Market Assessment

• Biopsy Devices Market Segmentation
  • Market Segmentation By  Product Type: Needles, Biopsy Systems, Forceps, Curettes, and Others
  • Market Segmentation By  Application: Skin Biopsy, Bone Marrow Biopsy, Prostate Biopsy, Breast Biopsy, and Others
  • Market Segmentation By Imaging Technology: Ultrasound-Guided, Mri-Guided Biopsy, and Stereotactic-Guided Biopsy
  • Market Segmentation By End User: PHospital, Diagnostic Centers, Imaging Centers, and Ambulatory Surgical Centers
  • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the biopsy devices market are set to emerge as the trendsetter explore @ Biopsy Devices Companies 

Table of Contents 

Interested in knowing the biopsy devices market by 2027? Click to get a snapshot of the Biopsy Devices Market Trends

Related Reports

Cancer Therapy Market

Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, among others.

Intratumoral Cancer Therapies Market

Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key intratumoral cancer therapies companies, including Daiichi Sankyo, Amgen, Idera Pharmaceuticals, among others.

Liquid Biopsy in Cancer Diagnostics Market

Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key liquid biopsy in cancer diagnostics companies, including Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, among others.

Metastatic Breast Cancer Pipeline

Metastatic Breast Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key metastatic breast cancer companies, including Roche, RemeGen, SynCore Biotechnology, among others.

Metastatic Castration-Sensitive Prostate Cancer Market

Metastatic Castration-Sensitive Prostate Cancer Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key metastatic castration-sensitive prostate cancer companies, including Astellas Pharma, Pfizer, Janssen Pharmaceutical, among others.

Small Cell Lung Cancer Pipeline

Small Cell Lung Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key small cell lung cancer companies, including Ascentage Pharma, Merck & Co, AstraZeneca, among others.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Blogs

Upcoming Oncological Drugs in 2023

Metastatic Castration-Sensitive Prostate Cancer Treatment Market

Checkpoint Inhibitor Refractory Cancer Market

Promising Oncolytic Virues Candidates in Pipeline

ENHERTU’s Journey in Cancer Treatment and Management

Potential of PD-1 and PD-L1 Inhibitors in Cancer Management

Evolving EGFR NSCLC Treatment Market Dynamics

Emerging Role of Digital Health in the Field of Oncology

Related Cases Studies

Competitive Intelligence

Market Assessment

Product Assessment

Epidemiology Assessment

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.